| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-08 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |